Duplicate Document
This document appears to be a copy. The original version is:
EFTA Document EFTA01452807Case File
efta-efta01452807DOJ Data Set 10CorrespondenceEFTA Document EFTA01452807
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01452807
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Healthcare
Original
Modified
Current
Total
Equity
Bristol Myers [GMT)
5
2.50
5
2:00
$
2.00
Pfizer [PPE)
5
2.50
5
2.00
5
2.00
Merck (MRK)
$
2.50
5
2.00
$
2.00
Valeant (VRX)
$
1.50
5
1.00
5
1.00
Actayis (ACT)
S
1.50
5
1.03
$
1.00
Gilead [GILD)
$
1.50
5
1.10 5
0.40 $
1.50
Myl a n [MVO
$
1.00
$
1.00
5
1.00
Endo Health (ENDP)
$
1.00
5
1.00
5
1.00
HCA Holdings (MCA)
5
0.50
$
1.00
$
1.00
Rite Aid 'RAD)
$
0.50
5
0.50
5
0.50
Foundation Medical [FMI)
5
0.70 5
0.70
Ariad [ARIA)
5
0.10 $
0.10
Sangamo Biosciences (56M0
5
1.00 $
1.00
Biogen IBIlB)
5
0.50
$
0.60 $
1.10
Agerion [AEGR)
5
0.50
$
0.50
WS Carernark [DA)
5
1.00
5
1.00
Healthcare Sub Total
$
15.00
$
14.60 5
2.80 $
17.40
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0 110069
CONFIDENTIAL
SDNY_GM_00256253
EFTA01452807
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.